These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 30621962)

  • 1. Hospital transfer after a breast cancer diagnosis: A population-based study in the Netherlands of the extent, predictive characteristics and its impact on time to treatment.
    Heeg E; Schreuder K; Spronk PER; Oosterwijk JC; Marang-van de Mheen PJ; Siesling S; Peeters MTFDV;
    Eur J Surg Oncol; 2019 Apr; 45(4):560-566. PubMed ID: 30621962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Breast Reconstruction on Time to Definitive Surgical Treatment, Adjuvant Therapy, and Breast Cancer Outcomes.
    Jabo B; Lin AC; Aljehani MA; Ji L; Morgan JW; Selleck MJ; Kim HY; Lum SS
    Ann Surg Oncol; 2018 Oct; 25(10):3096-3105. PubMed ID: 30014454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is mastectomy with immediate reconstruction safe for patients undergoing neoadjuvant chemotherapy? A nationwide study from Korean Breast Cancer Society.
    Park S; Jeong J; Han W; Lee YJ; Kim HA; Lee S; Do Byun K; Choi YJ; Kim J; Bae SY
    Breast Cancer; 2021 Jul; 28(4):874-883. PubMed ID: 33586091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nationwide population-based study of the impact of immediate breast reconstruction after mastectomy on the timing of adjuvant chemotherapy.
    Heeg E; Harmeling JX; Becherer BE; Marang-van de Mheen PJ; Vrancken Peeters MTFD; Mureau MAM
    Br J Surg; 2019 Nov; 106(12):1640-1648. PubMed ID: 31386193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does immediate breast reconstruction after mastectomy and neoadjuvant chemotherapy influence the outcome of patients with non-endocrine responsive breast cancer?
    Aurilio G; Bagnardi V; Graffeo R; Nolè F; Petit JY; Locatelli M; Martella S; Iera M; Rey P; Curigliano G; Rotmensz N; Munzone E; Goldhirsch A
    Anticancer Res; 2014 Nov; 34(11):6677-83. PubMed ID: 25368274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Shifting Paradigm for Breast Cancer Surgery in Patients Undergoing Neoadjuvant Chemotherapy.
    Kantor O; Ajmani G; Wang CH; Datta A; Yao K
    Ann Surg Oncol; 2018 Jan; 25(1):164-172. PubMed ID: 29127538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital organizational factors affect the use of immediate breast reconstruction after mastectomy for breast cancer in the Netherlands.
    Schreuder K; van Bommel ACM; de Ligt KM; Maduro JH; Vrancken Peeters MTFD; Mureau MAM; Siesling S
    Breast; 2017 Aug; 34():96-102. PubMed ID: 28552797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of Care in the Administration of Neo-adjuvant Chemotherapy for Breast Cancer. A Population-Based Study.
    Vugts G; Maaskant-Braat AJ; Nieuwenhuijzen GA; Roumen RM; Luiten EJ; Voogd AC
    Breast J; 2016 May; 22(3):316-21. PubMed ID: 26945566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delay of adjuvant chemotherapy after elective mastectomy and immediate reconstruction in breast-conservation candidates: a matched-pair analysis.
    Barry PN; Riley EC; Pan J; Crew JB; Lee K; Jain D; Kruse B; Quillo AR; Rai S; Dragun AE
    Am J Clin Oncol; 2014 Dec; 37(6):575-9. PubMed ID: 23466579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of mastectomy with immediate autologous latissimus dorsi breast reconstruction following neoadjuvant chemotherapy and radiation therapy: A single institution study of 111 cases of invasive breast carcinoma.
    Paillocher N; Florczak AS; Richard M; Classe JM; Oger AS; Raro P; Wernert R; Lorimier G
    Eur J Surg Oncol; 2016 Jul; 42(7):949-55. PubMed ID: 27134148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large variation between hospitals in immediate breast reconstruction rates after mastectomy for breast cancer in the Netherlands.
    van Bommel AC; Mureau MA; Schreuder K; van Dalen T; Vrancken Peeters MT; Schrieks M; Maduro JH; Siesling S
    J Plast Reconstr Aesthet Surg; 2017 Feb; 70(2):215-221. PubMed ID: 27993547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological complete response in invasive breast cancer treated by skin sparing mastectomy and immediate reconstruction following neoadjuvant chemotherapy and radiation therapy: Comparison between immunohistochemical subtypes.
    Barrou J; Bannier M; Cohen M; Lambaudie E; Gonçalves A; Bertrand P; Buttarelli M; Opinel P; Sterkers N; Tallet A; Zinzindohoué C; Houvenaeghel G
    Breast; 2017 Apr; 32():37-43. PubMed ID: 28033508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast conserving therapy after neoadjuvant chemotherapy; data from the Dutch Breast Cancer Audit.
    Spronk PER; Volders JH; van den Tol P; Smorenburg CH; Vrancken Peeters MTFD
    Eur J Surg Oncol; 2019 Feb; 45(2):110-117. PubMed ID: 30348601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
    van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
    Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Leading to Decreased Rates of Immediate Postmastectomy Reconstruction.
    Tung L; Jeong YJ; Lane C; Carey JN; Sposto R; Schechter NR; Sener SF; Lang JE
    J Surg Res; 2019 Jun; 238():207-217. PubMed ID: 30772679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Surgery Type on Time to Adjuvant Chemotherapy and Impact of Delay on Breast Cancer Survival: A National Cancer Database Analysis.
    Kupstas AR; Hoskin TL; Day CN; Habermann EB; Boughey JC
    Ann Surg Oncol; 2019 Oct; 26(10):3240-3249. PubMed ID: 31332635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant radiotherapy followed by mastectomy and immediate breast reconstruction : An alternative treatment option for locally advanced breast cancer.
    Pazos M; Corradini S; Dian D; von Bodungen V; Ditsch N; Wuerstlein R; Schönecker S; Harbeck N; Scheithauer H; Belka C
    Strahlenther Onkol; 2017 Apr; 193(4):324-331. PubMed ID: 28124093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding process-of-care delays in surgical treatment of breast cancer at a comprehensive cancer center.
    Golshan M; Losk K; Kadish S; Lin NU; Hirshfield-Bartek J; Cutone L; Sagara Y; Aydogan F; Camuso K; Weingart SN; Bunnell C
    Breast Cancer Res Treat; 2014 Nov; 148(1):125-33. PubMed ID: 25270121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between initiation of adjuvant chemotherapy beyond 30 days after surgery and overall survival among patients with triple-negative breast cancer.
    Heeg E; Marang-van de Mheen PJ; Van Maaren MC; Schreuder K; Tollenaar RAEM; Siesling S; Bos MEMM; Vrancken Peeters MTFD
    Int J Cancer; 2020 Jul; 147(1):152-159. PubMed ID: 31721193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in use of neoadjuvant chemotherapy in patients with stage III breast cancer: Results of the Dutch national breast cancer audit.
    Spronk PER; van Bommel ACM; Siesling S; Wouters MWJM; Vrancken Peeters MTFD; Smorenburg CH
    Breast; 2017 Dec; 36():34-38. PubMed ID: 28942098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.